Entering the Healthcare Market
As the world passed the mid-point of the 20th century, Elos company management recognized that their sophisticated skills and unique experience in precision engineering could be used to meet the overwhelming challenges within global healthcare.
Ground-breaking Innovation: Osseointegration
In 1975, we collaborated with Professor Per-Ingvar Brånemark on a project to develop osseointegration and manufactured the first dental implant for Brånemark.
Listing on NASDAQ Stockholm
In 1989, the former Aktiebolaget Götene – now called Westergyllen – enters the Nasdaq OMX Stockholm stock exchange in Sweden, to collect funding for growth and acquisitions.
Acquisition of Timmersdala Facility
The first important acquisition by Westergyllen is Elos AB, paving the way for increased focus on the healthcare area as contract manufacturer.
Westergyllen Listed on Stock Market Under Healthcare
On February 4th, 2008, AB Westergyllen became publicly traded on Nasdaq OMX Nordic under the healthcare category, opening doors to healthcare investors. Discover more…
Westergyllen Becomes Elos AB
In May same year, the new strategic intent of the company is redefined with a clear focus on precision applied to medical technology. The company changes name to Elos AB to emphasize this new direction. Discover more…
Elos Enters Chinese Market
In 1985, an exciting and expanding cooperation with Novo Nordisk was initiated. Elos signs a new agreement to participate in the creation of a new facility in Tianjin, China for the development and production of mechanical components. Following this agreement, Elos successfully establishes commercial operations in the Chinese market in 2009. Discover more…
Elos Medtech Acquires Microplast AB
The acquisition of Microplast AB, a Sweden-based company specialized in injection-molding for medical devices, complemented the precision-mechanics expertise in the medical technology business area.
Elos Medtech Becomes 100% Medical
As a completion of the direction started 50 years earlier, the executive board finalized the divestment of the metrology division, fully focusing on medical device and medical technology.
Acquisition of Onyx Medical, USA
The acquisition of Onyx Medical complemented Elos Medtech’s range of services and strengthened the group’s global footprint – now with facilities in Europe, Asia and the US.
Elos Medtech Expands Skara Facility
Following the increasing demand for injection-moulded plastic components, Elos Medtech expands the Skara site with 1500m2 to double the production capacity. Discover more…
Elos Expands Memphis Site
By doubling the manufacturing space and heavily investing in high-tech equipment for the Memphis site, Elos significantly increased its capacity to support customers in the global orthopedic market. Discover more…
Celebrating a Century of Success
The knack for precision that got us started, now permeates everything we do. In strong collaboration with our customers, we drive progress and advance medical devices within dentistry, orthopedics and life science – helping more people every day, in more places, regain functional abilities that restore their quality of life.
Elos Medtech Acquires Klingel
The acquisition of the Klingel Group in 2023 strengthened the group’s global presence while keeping a focus on local service. This union of two exceptional companies makes Elos Medtech one of the top 10 global players in the industry.